Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $248.36 +1.39%
Financial Fact:
Product sales, net: 371.62M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Product sales, net: 371.62M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q4 EPS of $1.17, $0.08 better than the analyst estimate of $1.09. Revenue for the quarter came in at $83.5 million versus the consensus estimate of $80.84 million.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
- Limoneira sells vineyard property for $15M at public auction
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
